RN7SKP233

Across TCGA pan-cancer cohorts, RN7SKP233 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RN7SKP233 data layer.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RN7SKP233 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP233 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

LUSC, LIHC, and DLBC are the cancer types where RN7SKP233 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUSC	OS	Tertile	All	0.126	0.762	<.001	108	view →
LIHC	OS	Tertile	All	0.195	0.777	.005	54	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	36	view →
KIRC	DFS	Tertile	IV	0.127	0.619	.008	36	view →
PCPG	DFS	Tertile	All	0.229	0.822	.024	18	view →
HNSC	DFS	Tertile	All	0.197	0.626	.045	9	view →
ESCA	DFS	Tertile	II,III,IV	1.000	0.330	.044	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RN7SKP233–LUSC (OS)

Open the LUSC breakdown →